CADL
Candel Therapeutics (CADL)
$35
About Candel Therapeutics (CADL)
Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.
Details
Daily high
$8.36
Daily low
$7.77
Price at open
$7.88
52 Week High
$8.36
52 Week Low
$4.35
Market cap
611.6M
Dividend yield
0.00%
Volume
38,587
Avg. volume
2.1M
P/E ratio
-11.91
Candel Therapeutics News
Details
Daily high
$8.36
Daily low
$7.77
Price at open
$7.88
52 Week High
$8.36
52 Week Low
$4.35
Market cap
611.6M
Dividend yield
0.00%
Volume
38,587
Avg. volume
2.1M
P/E ratio
-11.91